Patrick van Beneden
Director/Board Member at BIOTALYS NV
Network origin in Patrick van Beneden first degree
Entity | Entity type | Industry | |
---|---|---|---|
Gimv (Private Equity)
Gimv (Private Equity) Investment ManagersFinance Gimv (Private Equity) is a Private Equity firm, a subsidiary of Gimv NV (XB: GIMB) founded in 1980. Gimv (Private Equity) is headquartered in Antwerp, Belgium.
53
| Operating Division | Investment Managers | 53 |
23
| Public Company | Chemicals: Agricultural | 23 |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.
15
| Subsidiary | Biotechnology | 15 |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA.
13
| Extinct | Pharmaceuticals: Major | 13 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany.
12
| Subsidiary | Medical Specialties | 12 |
PamGene BV
PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland.
10
| Holding Company | Biotechnology | 10 |
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Complix NVengages in the development of biopharmaceutical company developing Alphabodies, a pipeline of transformative protein therapeutics. The Company is currently focusing its internal research and development activities on oncology and autoimmune diseases. Its therapeutic Alphabodies focuses on the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis and multiple sclerosis, and infectious diseases, and viral diseases such as influenza, HIV, and RSV. The company was founded by Mark Vaeck and Ignace Lasters in 2008 and is headquartered in Diepenbeek, Belgium.
9
| Holding Company | Pharmaceuticals: Major | 9 |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen.
8
| Private Company | Miscellaneous Commercial Services | 8 |
PamGene International BV
PamGene International BV Pharmaceuticals: MajorHealth Technology PamGene is a biomarker company, focused on opening up new opportunities for the development of Personalized Medicine (pre-clinical, translational and clinical). Most of PamGene's projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. The firm collaborators apply its technologies for biomarker research in several other diseases and fields of expertise such as the Central Nervous System, the Cardiovascular area, Immunology and Obesity. PamGene's technology offers a faster and lower risk route for discovery and development of clinically useful biomarkers and uses cell lines and retrospective patient sample collection testing.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Foundry Innovation & Research 1 Ltd.
Foundry Innovation & Research 1 Ltd. Medical SpecialtiesHealth Technology Foundry Innovation & Research 1 Ltd. develops novel therapeutic devices. It has evolved into one of the leading clusters for medical devices globally. The company was headquartered in Dublin, Ireland.
7
| Holding Company | Medical Specialties | 7 |
TPTX, Inc.
6
| Extinct | Miscellaneous Commercial Services | 6 |
Acertys NV
Acertys NV Medical DistributorsDistribution Services Acertys NV supplies medical equipment. The company is headquartered in Aartselaar, Belgium
4
| Subsidiary | Medical Distributors | 4 |
Xantos AG
Xantos AG Pharmaceuticals: MajorHealth Technology Xantos AG is a functional biology and drug discovery company developing biopharmaceuticals in the areas of cancer and metabolic diseases. Its business model is to develop drug discovery pipelines based on the validated targets and leads generated by its proprietary through target identification and validation system and to form indication specific joint research and development collaborations with pharmaceutical and biotechnology companies. It also offers customers its proprietary technology and cDNA/siRNA screening tools for research service deals. The company is headquartered in Munich, Germany.
2
| Private Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Patrick van Beneden via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Founder Founder Sales & Marketing Director/Board Member | |
Ghent University | College/University | Undergraduate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree Chief Operating Officer | |
Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
University of Antwerp | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ABLYNX | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Université Catholique de Louvain | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
CropDesign NV
CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | President Director of Finance/CFO Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
Université Libre de Bruxelles | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree | |
GIMV NV | Investment Managers | Chief Executive Officer Corporate Officer/Principal Chief Operating Officer Director of Finance/CFO | |
Sapiens Steering Brain Stimulation BV
Sapiens Steering Brain Stimulation BV Electronic Equipment/InstrumentsElectronic Technology Sapiens Steering Brain Stimulation BV develops medical devices. The company was founded by Sjaak Deckers in 2011 and is headquartered in Eindhoven, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member Chairman Director/Board Member Director/Board Member | |
University of Leiden | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
TIGENIX NV | Medical Specialties | Director/Board Member Founder Director/Board Member | |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Participatiemaatschappij Vlaanderen NV
Participatiemaatschappij Vlaanderen NV Investment ManagersFinance Participatiemaatschappij Vlaanderen NV (PMV) is a private equity/venture capital firm, a subsidiary of Region of Flanders founded in 1995. Participatiemaatschappij Vlaanderen NV is headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
ARGENX SE | Pharmaceuticals: Other | Director/Board Member Director/Board Member Director/Board Member | |
Vlerick Leuven Gent Management School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
deVGen NV
deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Corporate Officer/Principal Investor Relations Contact | |
Confo Therapeutics NV
Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Bayer Bioscience NV
Bayer Bioscience NV Chemicals: AgriculturalProcess Industries Part of Bayer AG, Bayer Bioscience NV is a Belgian company that manufactures and markets herbicides and agricultural chemical products. The private company is based in Ghent, Belgium. The company was founded by Gerard van Acker. | Chemicals: Agricultural | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Organon Teknika BV
Organon Teknika BV Medical SpecialtiesHealth Technology Organon Teknika BV manufactures HIV diagnostic products, including NucliSens HIV-1 viral load and nucliSens HIV-1 RNA detection assays. The company is headquartered in Boxtel, the Netherlands. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
University of Utrecht | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
BIOCARTIS GROUP NV | Medical Specialties | Director/Board Member Director/Board Member Chairman | |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Q-Biologicals NV
Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
EQT Life Sciences Group BV
EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor | |
Cegeka NV
Cegeka NV Information Technology ServicesTechnology Services Cegeka NV engages in the provision of information and communication technology solutions. It offers cloud, software, outsourcing, business process, digital experience, data and automation, and training services. The firm servers the agriculture, food, energy, utilities, manufacturing, retail, leisure, aviation, mobility, healthcare, and telecom industries. The company was founded by André Knaepen in 1992 and is headquartered in Hasselt, Belgium. | Information Technology Services | Director/Board Member Director/Board Member | |
Luciad NV
Luciad NV Packaged SoftwareTechnology Services Luciad NV designs and develops visualization and geospatial software products. The firm’s solutions include browser, server, AIXM 5 viewer, desktop, mobile, air traffic control and lucy test drive. The company was founded by Lode Missiaen and Thierry Salvant in 1999 and is headquartered in Leuven, Belgium. | Packaged Software | Director/Board Member Director/Board Member | |
VitrOmics Healthcare Holding BV
VitrOmics Healthcare Holding BV Pharmaceuticals: MajorHealth Technology VitrOmics Healthcare Holding BV is a holding company, which engages in the development of new diagnostic products based on the PamChip technology platform. Its platform is used for academic and bio-pharmaceutical research applications. The company was founded by Tim Kievits and is headquartered in 's-Hertogenbosch, the Netherlands. | Pharmaceuticals: Major | Founder Director/Board Member | |
ReWind Therapeutics NV
ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier. | Pharmaceuticals: Major | Chairman Director/Board Member | |
NovaMed Pharmaceuticals, Inc.
NovaMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NovaMed Pharmaceuticals Inc. engages in pharmaceutical preparations. It manufactures and distributes healthcare and pharmaceutical products. The company was founded by Mark Lotter, Min Geng Xiao and Bo Shao on August 1, 2005 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
University of Groningen | College/University | Graduate Degree Undergraduate Degree | |
ORANGE BELGIUM S.A. | Wireless Telecommunications | Director/Board Member Investor Relations Contact | |
University College Cork | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Zhuhai Seine Technology Co., Ltd.
Zhuhai Seine Technology Co., Ltd. Computer PeripheralsElectronic Technology Zhuhai Seine Technology Co., Ltd. is a holding company that manufactures printers and supplies printer consumables. It offers single funcation and multifunction printers, printer cartridges such as inkjet, laser and ribbon, and packaging . The company was founded by Jackson Wang on April 24, 2006 and is headquartered in Zhuhai, China. | Computer Peripherals | Director/Board Member Director/Board Member | |
CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member Director/Board Member |
Statistics
International
Belgium | 29 |
Netherlands | 13 |
United States | 4 |
China | 3 |
Germany | 2 |
Sectoral
Health Technology | 24 |
Consumer Services | 14 |
Commercial Services | 4 |
Finance | 4 |
Technology Services | 4 |
Operational
Director/Board Member | 679 |
Corporate Officer/Principal | 187 |
Chief Executive Officer | 95 |
Chairman | 79 |
Independent Dir/Board Member | 79 |
Most connected contacts
Insiders | |
---|---|
Ryan Drant | 52 |
Koen Dejonckheere | 46 |
Claus Asbjørn Andersson | 41 |
Chris Buyse | 39 |
Peter Barrett | 38 |
Regina Hodits | 33 |
Alex Brabers | 33 |
Jason S. Fisherman | 30 |
Bruno Montanari | 30 |
Catherine Moukheibir | 29 |
Roel Bulthuis | 29 |
Mounia Chaoui-Roulleau | 27 |
Jean Deleage | 23 |
Erik Amble | 23 |
Johannes G. C. P. Schikan | 22 |
- Stock Market
- Insiders
- Patrick van Beneden
- Company connections